and brain. LRBA deficiency (called LATAIE disease) may increase a person's risk of lymphoma, a type of cancer., autoimmunity, low levels of antibodies and recurrent infections. Excess of lymphocytes caused a variety of symptoms, LRBA deficiency due homozygous nonsense mutations. It is a rare genetic disorder of the immune system caused by mutation in LRBA gene. This disease results in excessive number of immune cells calls lymphocytes, lungs, the infiltration is most commun in the gut
Conditions
Brief summary
In comparison with a pre treatment period of five years improvement of quality of life, weight, diarrhea episode and number of hospitalisations
Detailed description
Expression of LRBA by PBMC, normalisation of CTLA4 expression of CD4 T cells. Normalisation of soluble CD25 and follicular T helper cells
Interventions
DRUGTranslarna 1000 mg granules for oral suspension
DRUGTranslarna 250 mg granules for oral suspension
Sponsors
Centre Hospitalier Universitaire De Liege
Eligibility
Sex/Gender
Male
Age
18 Years to 64 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In comparison with a pre treatment period of five years improvement of quality of life, weight, diarrhea episode and number of hospitalisations | — |
Secondary
| Measure | Time frame |
|---|---|
| Expression of LRBA by PBMC, normalisation of CTLA4 expression of CD4 T cells. Normalisation of soluble CD25 and follicular T helper cells | — |
Countries
Belgium
Outcome results
None listed